“GLP-1 medications are redefining the eating experience,” said Anisha Banerjee, Global Insights and Analytics, Tate & Lyle. “Our research reveals how taste, texture and satiety preferences are evolving; and how manufacturers can meet the moment with products that deliver nutrition and genuine enjoyment.”
